Vorinostat and Belinostat, hydroxamate-based anti-cancer agents, are nitric oxide donors

Reece G. Kenny, Ziga Ude, James R. Docherty, Celine J. Marmion

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Vorinostat and Belinostat, hydroxamate-based anti-cancer agents, are nitric oxide donors'. Together they form a unique fingerprint.

Chemistry

Pharmacology, Toxicology and Pharmaceutical Science